Work

Abstract 7021: Discovery of a highly potent and orally bioavailable ER PROTAC degrader for the treatment of breast cancer

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-7021

Authors: Guan Zhou, Yuanli Wang, Wei Xue, Yongzheng Ding, Jing Cheng, Kanghua Wang, Weiwei Yu, Wenmin Chen, Fuming Xu

Institution: Lee's Pharmaceutical (China)

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409630104

Cites:

Cited by:

Related to: 10